FDA drug guidance may threaten compliance for “literally every LTC facility,” pharmacy group says
New repackaging guidelines from the Food and Drug Administration could place “literally every LTC facility and associated pharmacy in America” at risk of failing to meet Medicare and Medicaid regulatory requirements, a senior care executive said last week.
During a June 6 FDA listening session, Senior Care Pharmacy Coalition President and CEO Alan Rosenbloom said the added regulations under the Drug Quality and Security Act could place the health and safety of LTC patients at risk.
Under the new policy, repacking drug products would become subject to a variety of different regulations, including repackaging timeframes and where the packaging can take place.
In a previous letter sent to the FDA by Rosenbloom in December 2015, he said the DQSA provisions would force pharmacies and regulatory reviewers to severely alter their policies, placing an increased financial burden on the repacking process.
He expressed these same concerns in the recent session, saying the provisions would “materially alter long-standing LTC pharmacy practices and procedures.”
He also said other organizations in the industry share his opinion.
Due to the high number of comments the FDA had received from those who would be affected by the provisions, Rosenbloom suggested an additional listening session take place before the guidelines were finalized.
Click here to see the original article on the McKnight’s website.
Recent Posts
-
Rep. Beth Van Duyne: Congress can save seniors’ access to medications before it’s too late
Seniors in nursing homes across the country depend on round-the-clock care and medications, perhaps more than any other American patient population. In turn, the nursing homes and assisted living facilities that care for them depend on a small number of specialized long-term care (LTC) pharmacies to ensure their patients have access to the prescription meds they need.
-
Bill Aims to Offset Reimbursement Losses for Long-Term Care Pharmacies Catering to Nursing Homes
Starting in January, falling prices for costly drugs may strain long-term care pharmacies, but proposed legislation backed by advocacy groups aims to subsidize some of this loss. And nursing home advocacy groups are among those urging Congress to pass the Preserving Patient Access to Long-Term Care Pharmacies Act.
-
Drug pricing policy could jeopardize long-term care pharmacies, leaders contend
Senior living and care leaders have joined a coalition calling attention to a policy fix they say would address unintended consequences of Medicare Part D price negotiations that could shutter long-term care pharmacies.
Stay in the Know
Get the latest news and updates on issues impacting the long-term pharmacy community.